Medications for Nasal Polyps
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Nasal Polyps.
Found 3 Approved Drugs for Nasal Polyps
Dupixent
Generic Name
Dupilumab
Dupixent
Generic Name
Dupilumab
Form: Injection
Method of administration: Subcutaneous
FDA approval date: March 28, 2017
Classification: Interleukin-4 Receptor alpha Antagonist
DUPIXENT is an interleukin-4 receptor alpha antagonist indicated: Atopic Dermatitis for the treatment of adult and pediatric patients aged 6 months and older with moderate-to-severe AD whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. DUPIXENT can be used with or without topical corticosteroids.
Nucala
Generic Name
Mepolizumab
Nucala
Generic Name
Mepolizumab
Form: Injection
Method of administration: Subcutaneous
FDA approval date: November 04, 2015
Classification: Interleukin-5 Antagonist
NUCALA is an interleukin-5 (IL-5) antagonist monoclonal antibody (IgG1 kappa) indicated for: Add-on maintenance treatment of adult and pediatric patients aged 6 years and older with severe asthma and with an eosinophilic phenotype.
Omalizumab
Brand Names
Xolair PFS, Xolair
Omalizumab
Brand Names
Xolair PFS, Xolair
Form: Injection
Method of administration: Subcutaneous
FDA approval date: June 20, 2003
Classification: Anti-IgE
XOLAIR is an anti-IgE antibody indicated for: Moderate to severe persistent asthma in adults and pediatric patients 6 years of age and older with a positive skin test or in vitro reactivity to a perennial aeroallergen and symptoms that are inadequately controlled with inhaled corticosteroids.
Showing 1-3 of 3
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances